ASHP and University of Minnesota Pharmacogenomics Accelerator: Update from Inaugural Cohort

Launched in 2022, the inaugural cohort seeks to expand pharmacogenomics services for patients across specialty areas and the entire medication use process.

Join ASHP and the University of Minnesota College of Pharmacy Tuesday afternoon to learn about the newly launched Pharmacogenomics Accelerator. The educational session highlights how the inaugural cohort of hospitals and health systems has committed to advancing patient care through pharmacogenomics. Our presenters are David Stenehjem, associate professor at the University of Minnesota College of Pharmacy, and Jill Bates, national pharmacogenomics action for cancer survivorship (PHASER) pharmacy program manager for the Department of Veterans Affairs, who serves as an expert strategic thought partner for the accelerator program.

The inaugural cohort was launched in September 2022. Each of the three implementation sites — Texas A&M Irma Lerma Rangel School of Pharmacy, Froedtert Health, and Wentworth-Douglass Hospital — has its own goals and objectives for joining the program. The cohort’s success is built on evidence-based implementation science methodology and the all-teach-all-learn approach supported by dedicated coaches and field experts assigned to the sites.

The pharmacy-led initiatives expand pharmacogenomics services for patients across specialty areas and the entire medication use process. The community of participants uses a team building guide, implementation workbook, practice management assessment, performance story guides, and a business plan to establish goals as participants work with their individual coach to overcome implementation challenges and barriers.

Bates’s presentation focuses on the need for pharmacogenomics, key elements, implementation challenges, cues to action, and self-efficacy.

The educational session concepts include:

• An effective approach can facilitate large-scale, multi-site, remote implementation of panel-based pharmacogenomics testing
• Relationships are the catalyst to implementing pharmacogenomics
• A coaching rather than an expert approach supports constructs of the health belief model, which may facilitate behavior change

After the session, attendees will be able to:

• Describe implementation facilitation
• Identify key elements of large-scale, multi-site, remote implementation facilitation of panel-based pharmacogenomics testing
• Apply the principles of coaching to pharmacogenomics implementation

To get in on the excitement, join us today from 2 to 3:30 p.m. in Mandalay Bay South Convention Center, South Seas F, level 3. For inquiries, or if your site is interested in joining the next cohort, please email [email protected].